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The Cape Town Declaration 
on access to cardiac surgery in 
the developing world
THE CAPE TOWN 
DECLARATION
THE MISSION
To urge all relevant entities within the international 
cardiac surgery, industry, and government sectors to 
commit to develop and implement an effective strategy 
to address the scourge of rheumatic heart disease in 
the developing world through increased access to life-
saving cardiac surgery.  SAHeart 2018;15:190-194
Twelve years after cardiologists and cardiac surgeons from all 
over the world issued the “Drakensberg Declaration on the 
Control of Rheumatic Fever and Rheumatic Heart Disease in 
Africa,” calling on the world community to address the 
prevention and treatment of rheumatic heart disease (RHD) 
through improving living conditions, to develop pilot pro-
grammes at selected sites for control of rheumatic fever and 
rheumatic heart disease, and to periodically review progress 
made and challenges that remain,(1) RHD still accounts for a 
major proportion of cardiovascular diseases in children and 
young adults in low- and middle-income countries, where more 
than 80% of the world population live. Globally equal in 
prevalence to human immunodeficiency virus infection, RHD 
affects 33 million people worldwide.(2)
Prevention efforts have been important but have failed to 
eradicate the disease. At the present time, the only effective 
treatment for symptomatic RHD is open heart surgery, yet that 
life-saving cardiac surgery is woefully absent in many endemic 
regions. In this declaration, we propose a framework structure 
to create a coordinated and transparent international alliance 
to address this inequality.
Elimination of RHD and relief from its debilitating consequences 
can only occur through interdisciplinary effort, as outlined in the 
Cairo Accord.(3) Previous initiatives have focused on primary 
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and secondary prevention of RHD.(4) Their declarations have 
been recognised by the Heads of State of African Union 
countries and by the World Health Organisation. This recog-
nition has been important in developing recommendations by 
the World Health Organisation Executive Board to the 2018 
World Health Assembly to enlist global commitment to RHD.
Progress in prevention of RHD has been slow during the past 
15 years,(5) and thus, surgery will likely remain an integral part 
of RHD treatment for several generations. Lack of access to 
cardiac surgery services and the cost of valve replacement 
render this disease fatal for millions of patients. In endemic 
regions of low-income countries, the need for cardiac surgery 
is estimated at 300 operations per 1 million population, yet, 
the nearly 1 billion people living in Sub-Saharan Africa between 
the Maghreb and South Africa have access to only 22 cardiac 
centers.(7) Although there is 1 cardiac center per 120 000 
people in the United States, there is only 1 center per 33 
million in Africa. Furthermore, RHD is not restricted to Sub-
Saharan Africa. India, Pakistan, China, and Indonesia together 
account for 72% of mortality of RHD cases worldwide.(2)
We strongly endorse the position that building local capacity is 
the best solution for this serious public health problem. Many 
lives have been saved by humanitarian “fly-in” missions, but 
these efforts are neither sustainable nor cost-effective. The 
non-governmental organisations associated with these pro-
grammes are shifting focus toward building long-term partner-
ships with host countries to develop autonomous local services 
with government buy-in.(8) A massive investment in new cardiac 
centers in these regions is unrealistic; globally, an additional 
few thousand cardiac centers would be required to address 
the unmet needs (”Global Unmet Needs in Cardiac Surgery,” 
unpublished work by Zilla and colleagues)(6).
It is not suff icient for governments and non-governmental 
organisations to support the training of cardiologists and cardiac 
surgeons from these regions at high-income country facilities, 
because they will not be trained in most of the pathologies 
awaiting them in their own countries and will be unfamiliar with 
resource-constrained circumstances.
There is an urgent need for a concerted effort by all stake-
holders to address the plight of the poor in these regions who 
need cardiac surgery. As signatories and endorsing organisations 
of the Cape Town Declaration, we propose a comprehensive 
solution with 2 principal aims.
AIM 1
To establish an international working group (coalition) of 
individuals from cardiac surgery societies and representatives 
from industry, cardiology, and government to evaluate and 
endorse the development of cardiac care in low- to middle-
income countries.
It is proposed that the international coalition will have 2 
representatives from each of the major cardiac surgery societies 
(The Society of Thoracic Surgeons, American Association for 
Thoracic Surgery, European Association for Cardio-Thoracic 
Surgery, The Asian Society for Cardiovascular and Thoracic 
Surgery), and ideally, 2 additional committed members. There 
will be at least 1 representative from industry and at least 1 
appointee to represent cardiology/the World Heart Federa-
tion. The responsibilities of the Coalition will include establish-
ing criteria for centers for clinical care and training as well as 
selecting and endorsing the centers. The Coalition will derive 
metrics of quality and performance for the endorsed centers 
of training and clinical care and will encourage standardisation 
of care to the extent possible.
The Coalition will advocate mutually agreed policies and 
prescriptions to relevant governmental bodies. In addition, the 
Coalition will engage industry and private sources of philan-
thropy for financial assistance with large-scale initiatives.
AIM 2
To advocate for the training of cardiac surgeons and other key 
specialised caregivers at identified and endorsed centers in low- 
to middle-income countries. 
The case has been made above for critical providers obtaining 
training in settings and conditions and dealing with the cardiac 
pathologies that they will be encountering in their practice in 
their countries of origin.
It is preferred that centers endorsed by this Coalition be 
based on an alliance of four stakeholders: a programme initiator 
(e.g., a government, a university, or a non-governmental orga-
nisation), an audited training center in a low- to middle-income 
country, a committed partner institution in a high-income 
country, and a consortium of industry that would sign on as 
benefactors to the specif ic programme. Because regional 
centers in low- to middle-income countries typically operate 
within a resource-scarce environment, resulting in lower case 
numbers than needed for the training of outside residents, 
a facilitated capacity increase to help achieve higher case 
numbers would benefit all participants.
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SUMMARY
It is imperative that action be taken urgently. A nucleus of 1 to 
3 centers should be identified and endorsed, with coordination 
by global stakeholders, as quickly as possible. The implementa-
tion of this initiative will only be made possible by the 
endorsement of all the relevant cardiothoracic societies and 
agencies subscribing to clearly defined targets and timelines, 
and committing appropriate resources. The time to act is now.
SIGNATORIES
For Cardiothoracic Societies (in alphabetical order)
Joseph Bavaria (Past-President, The Society of Thoracic 
Surgeons [STS], USA)
Friedhelm Beyersdorf (European Association for 
Cardiothoracic Surgery  [EACTS])
R. Morton Bolman, III (Representative, American Association 
for Thoracic Surgery [AATS], USA)
Kumud Dhital (Representative, Australian & New Zealand 
Society of Cardiac and Thoracic Surgeons [ANZSCTS], 
Australia)
Robert S.D. Higgins (President Elect, The Society of 
Thoracic Surgeons [STS], USA)
James Kirklin (Representative, American Association for 
Thoracic Surgery [AATS], USA)
Robert Kleinloog (President, Society of Cardiothoracic 
Surgeons of South Africa [SCTSSA], South Africa)
Bongani Mayosi (Past-President, Pan-African Society of 
Cardiology [PASCAR], South Africa)
Juan Mejia (Representative, Brazilian Society of Cardiovascular 
Surgery, Brazil)
Jose Pomar (Past President, European Association for 
Cardio-Thoracic Surgery [EACTS], Spain)
Karen Sliwa (President-Elect, World Heart Federation [WHF], 
South Africa)
Shinichi Takamoto (President, The Asian Society for 
Cardiovascular and Thoracic Surgery [ASCVTS], Japan)
Wei Wang (Representative, Chinese Society for Thoracic 
and Cardiovascular Surgery, China)
David Wood (President, World Heart Federation [WHF], 
United Kingdom)
Charles Yankah (President, Pan-African Society for 
Cardiothoracic Surgery [PASCaTS], Ghana/Germany)
Liesl Zühlke (President, South African Heart Association, 
South Africa)
Humanitarian and Government Organisations 
(in alphabetical order)
Alain Carpentier (Alain Carpentier Foundation, France)
Sylvain Chauvaud (La Chaîne de l’Espoir, France)
Afksendiyos Kalangos (President: Kalangos Foundation, 
Greece)
Richard Kamwi (Past Minister of Health, Namibia)
René Preˇtre (Le Petit Coeur, Switzerland)
Nicole Sekarski (Le Petit Coeur, Switzerland)
Magdi Yacoub (President, Chain of Hope, United Kingdom/
Egypt)
Industry and Health Economy representatives 
(in alphabetical order)
Iraj Abedian (Pan-African Capital Holdings, South Africa)
Francois Bonnici (Director, Bertha Centre for Social Innovation 
and Entrepreneurship, South Africa)
Lenias Hwenda (Chief Executive Officer, Medicines for Africa, 
Zimbabwe/Switzerland)
Sidhant Jena (Chief Executive Officer, Jana Care, USA)
Samukeliso Dube (Chief Medical Officer, Royal Philips, 
Netherlands)
Jacques Kpodonu (Author, Global Health Innovations, 
USA/Ghana)
Salah Malek (President, Middle East and Africa, Getinge, 
United Arab Emirates)
Markus Stirner-Schilling (VP Marketing & Academy, Europe, 
Middle East & Africa, Getinge, Germany)
Patrice Matchaba (Global Head Corporate Responsibility, 
Novartis, Switzerland)
Lee Chuen Neng (Biomedical Institute for Global Health 
Research & Technology, Singapore)
Michael P. Phalen (Executive President, MedSurg Boston 
Scientific, USA)
Tim Ring (Chairman and Chief Executive Officer, C.R. Bard 
Inc., USA)
Kathryn Gleason (Co-Founder, TeamFund Inc.)
Devi Prassad Shetty (NH Group, India)
Alistair Simpson (General Manager Cardiac Surgery, LivaNova, 
United Kingdom)
Raenette Taljaard (“Economic Research of South Africa” 
[ERSA], South Africa)
Helmut Straubinger (Ex Chief Executive Officer, Jena Valve; 
Chief Executive Officer, Tricares, Germany)
Barry Wilson (Former President, Medtronic International)













For Major Journals and Publications 
(in alphabetical order)
Friedhelm Beyersdorf (Editor in Chief, European Journal of 
Cardio-Thoracic Surgery, Germany)
Sampath Kumar (Editor in Chief, Asian Cardiovascular and 
Thoracic Annals, India)
Dan Ncayiyana (Past Editor in Chief, South African Medical 
Journal, South Africa)
J.P. van Niekerk (Past Editor in Chief, South African Medical 
Journal, South Africa)
G. Alexander Patterson (Editor in Chief, The Annals of 
Thoracic Surgery, USA)
Marko Turina (Past Editor in Chief, European Journal of 
Cardio-Thoracic Surgery; Past Editor in Chief, Cardiothoracic 
Surgery Network [CTSNet] and Multimedia Manual of 
Cardio-Thoracic Surgery, Switzerland)
David Williams (Past Editor in Chief, Biomaterials, USA)




Henning Rud Andersen (Denmark)
Manuel Antunes (Portugal)
Eduardo Becerra (Chile)






Johan Brink (South Africa)
Taweesak Chotivatanapong (Thailand)





Frederick C de Beer (USA)























Willie Koen (South Africa)
Gennadiy Khubulava (Russia)










Ana Olga Mocumbi (Mozambique)
Elmi Muller (South Africa)
Mathias Mueller (Austria)
Paul Mohacsi (Switzerland)
Ivan Netuka (Czech Republic)
Mpiko Ntsekhe (South Africa)
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Minoru Ono (Japan)
Otmar Pachinger (Austria)
Timothy Pennel (South Africa)
Olga Plattner (Austria)
Bruno Podesser (Austria)




Jacques Scherman (South Africa)






Francis Smit (South Africa)
Ulrich Steinseifer (Germany)
Cynthia St. Hilaire (USA)










Conflict of interest: none declared. 
REFERENCES
1.  Mayosi B, Robertson K, Volmink J, et al. The Drakensberg declaration on the 
control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med 
J 2006;96:246.
2.  Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and 
national burden of rheumatic heart disease, 1990 - 2015. N Engl J Med 
2017;377:713-22.
3.  Yacoub M, Mayosi B, El Guindy A, Carpentier A, Yusuf S. Eliminating acute 
rheumatic fever and rheumatic heart disease. Lancet 2017;390:212-3.
4.  Watkins D, Zühlke L, Engel M, et al. Seven key actions to eradicate rheumatic 
heart disease in Africa: The Addis Ababa communique. Cardiovasc J Afr 
2016;23:184-7.
5.  Zühlke LJ, Karthikeyan G. Primary prevention for rheumatic fever. Global 
Heart 2013;8:221-6.
6.  Zilla P, Yacoub M, Zühlke L, et  al. Global unmet needs in Cardiac Surgery. 
Global Heart 2018 (in print).
7.  Yankah C, Fynn-Thompson F, Antunes M, et al. Cardiac surgery capacity in 
sub-Saharan Africa: Quo vadis? Thorac Cardiovasc Surg 2014;62:393-401.
8.  Swain J, Sinnott C, Breakey S, et al. Ten-year clinical experience of humani-
tarian cardiothoracic surgery in Rwanda: Building a platform for ultimate 
sustainability in a resource-limited setting. J Thorac Cardiovasc Surg 2018;
155:2541-50.
